BWS
BBIO icon

Buck Wealth Strategies’s BridgeBio Pharma BBIO Stock Holding History

Buck Wealth Strategies’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64K Buy
+22
New +$1.54K ﹤0.01% 887

Other funds holding BBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Buck Wealth Strategies's BBIO Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 22 shares worth $1.64K. The stake represents ﹤0.01% of the portfolio and ranks #887 among its holdings.

204 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Buck Wealth Strategies held 22 shares of BridgeBio Pharma worth $1.64K as of Q2 2026.
  • BridgeBio Pharma was a new Buck Wealth Strategies position in Q2 2026.
  • BridgeBio Pharma made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #887 holding.
  • 204 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.